
1001 - 5000 employees
π Pharmaceuticals
π₯ Healthcare
𧬠Biotechnology
Pharmaceuticals β’ Healthcare β’ Biotechnology
Otsuka Pharmaceutical Companies (U. S. ) is a prominent player in the pharmaceutical manufacturing industry, dedicated to creating innovative products for better health worldwide. The company comprises two main entities: Otsuka America Pharmaceutical, Inc. (OAPI), which is focused on commercializing Otsuka-discovered and in-licensed products in North America, and Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), which specializes in the clinical development and global registration of innovative healthcare solutions, particularly in the field of neuroscience.
π September 22
πΊπΈ United States β Remote
π΅ $186.5k - $278.9k / year
β° Full Time
π΄ Lead
π Director
π» Ghost score 8%
Where this job comes from
Posted on Otsuka Pharmaceutical Companies (U.S.)'s careers page β, not through a job board
First seen by Remote Rocketship September 22
Still open on Otsuka Pharmaceutical Companies (U.S.)'s site. Checked 5 hours ago.

1001 - 5000 employees
π Pharmaceuticals
π₯ Healthcare
𧬠Biotechnology
Pharmaceuticals β’ Healthcare β’ Biotechnology
Otsuka Pharmaceutical Companies (U. S. ) is a prominent player in the pharmaceutical manufacturing industry, dedicated to creating innovative products for better health worldwide. The company comprises two main entities: Otsuka America Pharmaceutical, Inc. (OAPI), which is focused on commercializing Otsuka-discovered and in-licensed products in North America, and Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), which specializes in the clinical development and global registration of innovative healthcare solutions, particularly in the field of neuroscience.
β’ Lead strategy and programs reducing barriers to disease recognition, specialist referral, diagnosis, genetic testing and counseling, and connection to specialty care β’ Lead compliant, unbranded disease education and diagnostic-pathway readiness before approval β’ Lead branded patient and caregiver marketing following approval β’ Partner with Patient Services on support-experience and persistence programs using aggregate, deidentified data β’ Own omnichannel strategy and execution for unbranded market-development and disease-education programs and, following approval, branded patient and caregiver programs β’ Establish shared audience-journey frameworks, channel-orchestration standards, marketing-technology and data requirements, and measurement approaches β’ Lead development, execution, and measurement of unbranded HCP disease-state peer-to-peer programs β’ Build symptom- and pathway-oriented education for patients, caregivers, and clinicians β’ Define commercial requirements for genetic-testing access programs β’ Own the annual plan, budget, agency and vendor execution, and aggregate performance measures β’ Serve as primary marketing liaison to the Omnichannel Business Partner β’ Co-lead the advertising Agency of Record relationship β’ Identify recurring system-level barriers using research, advocacy insights, and aggregate data β’ Lead commercial responses to recurring genetic-testing, specialist-referral, treatment-center connection, and support barriers β’ Lead or support patient and caregiver advisory boards β’ Partner with advocacy organizations to extend education, referral, and support resources β’ Coordinate with National Patient Advocacy on strategy, funding governance, and content independence β’ Partner with Medical Affairs, Market Access, HUB/Patient Services, TLL, Account Managers, and Brand Strategy & HCP Engagement β’ Set national market-development and patient-journey priorities and equip field teams with approved programs and aggregate insights β’ Contribute to congress strategy and cross-functional launch planning
β’ At least 10 years of commercial experience in the U.S. biopharmaceutical industry β’ Experience including market development, disease education, patient marketing, digital and omnichannel engagement, new-product launches, and market analysis β’ Recent rare disease commercialization experience required β’ Demonstrated pre-launch experience building compliant unbranded education and pathway programs β’ Post-approval patient marketing experience β’ Demonstrated success partnering with patient advocacy organizations under appropriate governance β’ Diagnostics, genetics, neurology, or diagnostic-pathway market development strongly preferred β’ MBA or relevant graduate degree preferred β’ Up to 30% travel based on business needs
β’ Incentive opportunity β’ Comprehensive medical, dental, vision, and prescription drug coverage β’ Company-provided basic life insurance β’ Accidental death and dismemberment insurance β’ Short-term and long-term disability insurance β’ Tuition reimbursement β’ Student loan assistance β’ Generous 401(k) match β’ Flexible time off β’ Paid holidays β’ Paid leave programs β’ Other company-provided benefits
Apply NowImprove your chances of getting an interview by checking your resume score before you apply.
π September 22
Commercial Director leading US enterprise sales for Nearaβs AI-powered electricity-grid digital twins. Managing Account Executives, regional revenue, forecasting, strategic accounts, and customer growth.
πΊπΈ United States β Remote
π΅ $200k - $225k / year
π° Series B on 2022-05
β° Full Time
π Senior
π΄ Lead
π Director
π September 22
Senior technology leader delivering clinical IT solutions for U.S. Anesthesia Partners, a nationwide anesthesia practice. Overseeing application development, automation, platforms, support, vendors, and technical teams.
π September 22
1001 - 5000
π₯ Healthcare
𧬠Biotechnology
π Pharmaceuticals
Health Systems Director advancing hospital access and sales for Sobiβs rare-disease therapies. Managing health-system stakeholders, formulary pathways, clinical education, and account plans in North Texas.
πΊπΈ United States β Remote
π΅ $180k - $220k / year
β° Full Time
π Senior
π΄ Lead
π Director
π September 22
Operational efficiency director improving technology and processes for Strongpoint Partnersβ retirement plan administration platform. Leading system migrations, adoption, and scalable straight-through processing.
π September 22
Director leading field execution, national meetings, and cross-functional programs for Madrigalβs MASH therapeutics commercialization. Driving field readiness, adoption, process improvement, budgets, and vendor performance.
πΊπΈ United States β Remote
π° $259M Post-IPO Equity on 2022-12
β° Full Time
π Senior
π΄ Lead
π Director
π¦ H1B Visa Sponsor